Simplex Trading
GENE

Simplex Trading’s Genetic Technologies Ltd. GENE Stock Holding History

Simplex Trading’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-380
Closed -$3K – 11409
2022
Q1 		$3K Sell
380
-1,960
-84% -$19K ﹤0.01% 9769
2021
Q4 		$21K Sell
2,340
-10,360
-82% -$133K ﹤0.01% 8331
2021
Q3 		$271K Hold
12,700
– – ﹤0.01% 5082
2021
Q2 		$269K Buy
12,700
+12,643
+22,181% +$255K ﹤0.01% 5173
2021
Q1 		$118K Buy
57
+5
+10% +$114 ﹤0.01% 5514
2020
Q4 		$92K Buy
52
+38
+271% +$628 ﹤0.01% 5528
2020
Q3 		$23K Buy
+14
New +$261 ﹤0.01% 6281
2018
Q2 		– Sell
-1
Closed -$2K – 8013
2018
Q1 		$2K Buy
+1
New +$29 ﹤0.01% 5388

Other funds holding GENE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
ATS
Ashton Thomas Securities Rochester, New York $797M AUM 18.33% 1-Year Est. Return

Simplex Trading's GENE Position: Q3 2024 in Review

Simplex Trading sold out of Genetic Technologies Ltd. (GENE) in Q3 2024, closing a stake of 255 shares.

Simplex Trading first reported a position in GENE in Q4 2015 and held it in 19 quarters. The position peaked at $112K in Q1 2021. 10 funds tracked by Wall St. Rank hold GENE as of Q3 2024.

  • Simplex Trading reported no remaining Genetic Technologies Ltd. position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 255 Genetic Technologies Ltd. shares in Q3 2024.
  • Simplex Trading first reported a position in Genetic Technologies Ltd. in Q4 2015 and held it in 19 quarters.
  • Simplex Trading's Genetic Technologies Ltd. position peaked at $112K in Q1 2021.
  • 10 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.